Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Integrative analysis of a novel signature incorporating metabolism and stemness-related genes for risk stratification and assessing clinical outcomes and therapeutic responses in lung adenocarcinoma

Fig. 4

The correlation between the prognostic risk signature and clinicopathological characteristics in the TCGA_LUAD cohort. A-E Comparison of the risk score across different subgroups stratified by clinicopathological characteristics, including age (A), gender (B), pathological stage (C), T stage (D), and N stage (E). F-J Kaplan-Meier curves depicting the probability of OS stratified by the same clinicopathological characteristics: age (F), gender (G), pathological stage (H), T stage (I), and N stage (J). K, L Cox regression analyses for univariate (K) and multivariate (L) models, incorporating age, gender, pathological stage, T stage, N stage, and risk score as factors. OS, overall survival; T, tumor size; N, lymph node metastasis; ns, no significance. Statistical significance is indicated as * P < 0.05 and *** P < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us